Introduction
SAS JMP Statistical Discovery Clinical 2024 is a specialized desktop software suite from SAS Institute. Tailored for clinical research and healthcare analytics it delivers interactive graphics robust statistical modeling clinical trial monitoring and automated patient reporting—all within a user-friendly interface
Features
- Comprehensive statistical tools for clinical trial data analysis data integrity checks survival analysis and advanced modeling
- Automated patient profiles & narratives—reducing manual reporting workload and facilitating regulatory compliance
- Data visualization & dashboards: interactive graphical outputs and summary panels for safety and quality monitoring
- CDISC/SDTM conversion tools: import raw clinical datasets and transform to standard formats for submission
- Customizable reporting with templates to streamline repeated analysis
- Integration with SAS, R, MATLAB etc.—leveraging JMP’s scripting language (JSL) for automation
.png)
Read Also: Thinkbox Deadline Free Download
Technical Setup Details
- Installer: Offline standalone package (~728 MB file JMP_Clinical_18.rar) for Windows (32‑bit & 64‑bit)
- Release date: July 8–9, 2024
- Supported languages: English Japanese Simplified Chinese (multi-language pack)
- Architecture: x64 Windows only
System Requirements
According to GetIntoPC (July 2024):
- OS: Windows 7/8/10 (32 or 64‑bit)
- CPU: Intel Dual‑Core or higher
- RAM: 2 GB minimum (though JMP docs recommend 8–16 GB for clinical modules)
- Disk Space: 1 GB minimum—again real-world usage often needs 10–15 GB+
Note: SAS/JMP’s official clinical edition often assumes:
-
CPU: Pentium 4+ RAM: 8 GB+ Disk: 128 GB+
Your real-world needs may be higher depending on dataset size and complexity.

Conclusion
SAS JMP Statistical Discovery Clinical 2024 is a powerful analytics platform for clinical professionals and researchers. It combines:
- Rich statistical analysis and CDISC/SDTM conversion
- Automated reporting
- Interactive dashboards and
- Integration with broader SAS/R ecosystems.
0 Comments